These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35594552)

  • 1. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021-November 2021.
    Levin-Rector A; Firestein L; McGibbon E; Sell J; Lim S; Lee EH; Weiss D; Geevarughese A; Zucker JR; Greene SK
    Clin Infect Dis; 2023 Feb; 76(3):e469-e476. PubMed ID: 35594552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January-June 2021.
    Peebles K; Arciuolo RJ; Romano AS; Sell J; Greene SK; Lim S; Mulready-Ward C; Ternier A; Badenhop B; Blaney K; Real JE; Spencer M; McPherson TD; Ahuja SD; Sullivan Meissner J; Zucker JR; Rosen JB
    J Infect Dis; 2023 Feb; 227(4):533-542. PubMed ID: 36626187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021.
    Good MK; Czarnik M; Harmon KG; Aukerman D; O'Neal CS; Day C; Goerl K; Sifre K; Fink S; Riggs MA
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S236-S242. PubMed ID: 35771661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vaccination on SARS-CoV-2 reinfection risk: a case-control study in the Republic of Cyprus.
    Quattrocchi A; Tsioutis C; Demetriou A; Kyprianou T; Athanasiadou M; Silvestros V; Mamais I; Demetriou CA; Theophanous F; Soteriou S; Gregoriadou C; Anastasiou E; Kolios P; Ηaralambous C; Gregoriou I; Kalakouta O; Nikolopoulos G
    Public Health; 2022 Mar; 204():84-86. PubMed ID: 35193032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological assessment of SARS-CoV-2 reinfection.
    Almadhi M; Alsayyad AS; Conroy R; Atkin S; Awadhi AA; Al-Tawfiq JA; AlQahtani M
    Int J Infect Dis; 2022 Oct; 123():9-16. PubMed ID: 35931371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Ann Intern Med; 2022 May; 175(5):674-681. PubMed ID: 35157493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 reinfections in Mexico City: implications for public health.
    de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
    Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection.
    Sánchez-de Prada L; Martínez-García AM; González-Fernández B; Gutiérrez-Ballesteros J; Rojo-Rello S; Garcinuño-Pérez S; Álvaro-Meca A; Ortiz De Lejarazu R; Sanz-Muñoz I; Eiros JM
    Sci Rep; 2024 Jan; 14(1):353. PubMed ID: 38172152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At what frequency of vaccination do the vaccinated potentially pose an equal risk to the unvaccinated for transmission of SARS-CoV-2 inside restaurants in New York City?
    Wormser GP; Visintainer P
    Wien Klin Wochenschr; 2022 Dec; 134(23-24):828-830. PubMed ID: 35947224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.
    Zheng H; Wu S; Chen W; Cai S; Zhan M; Chen C; Lin J; Xie Z; Ou J; Ye W
    Front Public Health; 2024; 12():1457266. PubMed ID: 39253287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
    Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
    Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
    Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
    JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.